RALPH HADLEY: Open Payments
NPI 1295959211 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,021 in 44 payments from 18 companies in 2025. Trend: 2023 $726 · 2024 $959 · 2025 $1,021
Food & beverage: $1,021
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $227 |
| AstraZeneca Pharmaceuticals LP | 7 | $150 |
| Axsome Therapeutics, Inc. | 4 | $107 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $74 |
| Lilly USA, LLC | 3 | $72 |
| ABBVIE INC. | 2 | $55 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Dexcom, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
Products named: Rybelsus, AIRSUPRA, JARDIANCE, Auvelity, VRAYLAR, Dexcom G6 Transmitter, CAPLYTA, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
